Dr Dhamrait (cardiology) and Professor Shakur (Core Director) along with a UK medical device manufacturer have secured approval by the MHRA for a world’s first clinical trial on the application of novel cardiac monitoring in real time for patient screening. The trial will be instigated with the Sussex Foundation trust and will be the first time such a wirelessly charged real time multi lead ecg device has been tested in the world . The clinical team will begin recruitment in 2024!